Why Still in Neurosurgical Ward After Tumor Craniotomy?

Brain Tumor Clinical Trial

Official title:

Factors Associated With Prolonged In-hospital Stay After Elective Tumor Craniotomy.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05288088
• Other study ID #: NSwardcraniotomy
• Status: Completed
• Start date: June 12, 2022
• Est. completion date: November 15, 2023

Study information

• Verified date: November 2023
• Source: Rigshospitalet, Denmark
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this prospective observational study is to identify the specific reasons that prolong a hospital stay after elective tumor craniotomy. Optimal postoperative in-hospital stay is considered to be two days from surgery to discharge from the neurosurgical ward. However, a variable length of stay at a neurological department for follow-up of late recognized deficits of neurological consequences of the surgical procedure are common.

Description:

The concept of fast-track surgery and later enhanced recovery after surgery (ERAS) was first imputed in 1990s. Since then, ERAS protocols have been successfully adopted in many surgical fields, often with dramatic benefits for the patients. Length of hospital stay is one of the main questions addressed in many ERAS studies, as it by a simple approach address many of the complications encountered by the patients or the case flow in the perioperative period. Why patients have prolonged hospital stay after surgery has been investigated by Husted et al. in 2011 after hip and knee arthroplasty and P. Munk-Madsen et al. in 2019 after laparoscopic colorectal surgery. Both studies could isolate dominating factors prolonging hospital stay, some of them preventable. Existing length of stay studies on tumor craniotomy patients have focused on specific variables affecting hospital duration, but never explored the true cause of prolonged hospitalization.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: November 15, 2023
• Est. primary completion date: June 28, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients scheduled for elective brain tumor craniotomy

Exclusion Criteria:

• Stereotactic biopsy, pituitary surgery and laser interstitial thermal therapy (LITT)

Related Conditions & MeSH terms

• Brain Neoplasms
• Brain Tumor
• Surgery--Complications

Intervention

Diagnostic Test:
• No intervention
This is an observational study

Locations

Country	Name	City	State
Denmark	Department of Neuroanesthesiology, Rigshospitalet	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital length of stay	Length of stay is defined as the length of inpatient stay, based on number of nights spent at the neurosurgical ward, calculated from the day of surgery to the day of discharge from the neurosurgical ward.	Patients are followed for a maximum of 6 months.